Literature DB >> 15869920

Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

A Valenta1, P Roschger, N Fratzl-Zelman, P J Kostenuik, C R Dunstan, P Fratzl, K Klaushofer.   

Abstract

The combination of PTH with OPG has been proposed as a potential therapy in patients with severe osteoporosis. In the present study, we examined the bone material of aged ovariectomized (OVX) rats treated either with PTH (1-34) or OPG alone or in combination of both. The micro- and nanostructural characteristics of the mineralized bone were evaluated using quantitative backscattered electron imaging (qBEI) and small-angle X-ray scattering (SAXS). Rats (n=68) were either sham-operated or ovariectomized (OVX) at the age of 3 months, and 15 months later, OVX animals were treated either with vehicle, OPG (10 mg/kg), PTH (80 microg/kg) or a combination of both during 5.5 months. All treatments were by subcutaneous injection, 3 days per week. Secondary metaphyseal spongiosa from distal femora was assessed for mineralized bone volume (BV/TV), for the mean Ca-concentration (Camean), the width of the bone mineralization density distribution (Cawidth), as well as the average mineral particle thickness parameter (T) and the degree of alignment of the mineral particles (rho). A remarkable increase of BV/TV up to 139% (P<0.001) was observed in the PTH-treated groups independently of OPG. Camean was slightly increased (+1.7%, P<0.05) in the OPG-treated group. Cawidth was reduced (-6.4%, P<0.01, and -8.9%, P<0.001) in animals treated with OPG and PTH+OPG, respectively. In contrast, Cawidth in sham-operated rats was 16.0% (P<0.001) higher than in OVX. The T parameter was not altered in the trabecular bone within the group of treated and untreated OVX rats. However, the non-ovariectomized animals exhibited a significantly lower T value (-7.1%, P<0.01) with respect to OVX. In conclusion, qBEI and SAXS data of OVX rats suggest that PTH alone was responsible for increase of bone volume, whereas OPG positively influenced the homogeneity and density of mineralization without affecting the nanostructure of the bone material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869920     DOI: 10.1016/j.bone.2005.03.013

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

2.  Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.

Authors:  D Yang; R Singh; P Divieti; J Guo; M L Bouxsein; F R Bringhurst
Journal:  Bone       Date:  2007-02-16       Impact factor: 4.398

3.  Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial.

Authors:  A J Prati; M Z Casati; F V Ribeiro; F R Cirano; G P Pastore; S P Pimentel; R C V Casarin
Journal:  J Dent Res       Date:  2013-10-24       Impact factor: 6.116

4.  Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency.

Authors:  Divya Sharma; Cesare Ciani; Paula A Ramirez Marin; Jessica D Levy; Stephen B Doty; Susannah P Fritton
Journal:  Bone       Date:  2012-05-23       Impact factor: 4.398

5.  The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys.

Authors:  M S Ominsky; P J Kostenuik; P Cranmer; S Y Smith; J E Atkinson
Journal:  Osteoporos Int       Date:  2007-03-24       Impact factor: 4.507

6.  Densitometry, radiography, and histological assessment of collagen as methods to evaluate femoral bones in an experimental model of osteoporosis.

Authors:  L Hernandes; A L Ramos; K R Micheletti; A P Santi; O A Cuoghi; M Salazar
Journal:  Osteoporos Int       Date:  2011-02-10       Impact factor: 4.507

7.  Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.

Authors:  Yang Yang; Ali Aghazadeh-Habashi; Arash Panahifar; Yuchin Wu; Krishna H Bhandari; Michael R Doschak
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

8.  Secondary alterations in bone mineralisation and trabecular thickening occur after long-term estrogen deficiency in ovariectomised rat tibiae, which do not coincide with initial rapid bone loss.

Authors:  L M O'Sullivan; H Allison; E E Parle; J Schiavi; L M McNamara
Journal:  Osteoporos Int       Date:  2019-11-30       Impact factor: 4.507

Review 9.  The cell biology of parathyroid hormone in osteoblasts.

Authors:  Stavroula Kousteni; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2008-06       Impact factor: 5.096

10.  Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT.

Authors:  J E M Brouwers; B van Rietbergen; R Huiskes; K Ito
Journal:  Osteoporos Int       Date:  2009-03-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.